Back to Search

Aujla, Amandeep, MD

Gender

Male


Language

English, Hindi, Punjabi

Providing the best care to our patients and their companions requires communicating in a way everyone understands. Interpreter services are available 24 hours a day, 7 days a week, 365 days a year. All spoken languages are available, as well as American Sign Language (AS/L).


Specialties
Accepting New Patients
  • Hematology / Oncology
  • Medical Oncology

Areas of Expertise
Colorectal Cancer, Esophageal Cancer, Gastrointestinal Malignancies, Lung Cancer, Neuro-oncology, Prostate Cancer, Thoracic Cancers

Education

Fellowship
New York Medical College

Internship
New York Medical College

Medical School
Government Medical College Patiala

Residency
New York Medical College

Reviews

Verified Patient Reviews

5 out of 5 stars

Dr. Aujla articulate, patient,clear in explanation, and kind

5 out of 5 stars

Very attentive to my needs

4 out of 5 stars

I left not understanding my condition and the steps to change it

5 out of 5 stars

I really feel *Dr. Aujla is sincerely compassionate.

5 out of 5 stars

The Dr took time to be very thorough and had a good bedside manner


Other Reviews from Around the Web

5 out of 5 stars

Dr Aujla listens, takes time to discuss issues and responds quickly to further questions. I feel he is invested in my care.

5 out of 5 stars

My first time here. The team was friendly and professional. Doctor Aujla took his time to ask questions, explain my condition and answered all my concerns and questions. The place was also new and cleaned.

Bio

Amandeep Aujla, MD, joined the Hartford Healthcare Cancer Institute in July 2020, and practices in the Norwich and Waterford offices. His practice is evolving and he sees patients with broad diagnoses of cancer with special interest in thoracic oncology, neuro-oncology and melanoma. After earning a medical degree in India, Dr. Aujla completed an internship, residency and fellowship in hematology and oncology at New York Medical College, where he also served as chief fellow in his third year. He has authored and participated in different projects focusing on breast cancer, kidney cancer, hematological malignancies, engraftment fever during stem cell transplantation and sickle cell disease. He also worked under the mentorship of Dr. Seah Lim, evaluating the role of targeting intestinal pathophysiology in decreasing vaso-occlusive crises in Sickle Cell Disease. The work led to the Food & Drug Administration designating Rifaxmin an orphan drug treatment for the disease.

Insurance

Aetna, Anthem, BCBS Medicare, CarePartners of Connecticut, Cigna Healthcare, Colonial Cooperative Care, Community Health Network of Connecticut, Inc., Connecticare, Connecticare Commercial, Connecticare Medicare, Corvel, Coventry, Essence Healthcare, Evercare, First Health Group Corp., Focus, Health Connecticut, Health Direct, Health New England, Healthy Connecticut, Multiplan, Northeast Health Direct, One Health Plan/ Great-West Healthcare, Oxford Health Plans, Prime Health Services, Private Health Care Systems, Inc., Senior Whole Health, United Healthcare, WellCare of Connecticut, Inc.

This information is subject to change at any time. Please check with your insurance provider before scheduling your appointment or receiving services to confirm they are a participating member of the Hartford HealthCare network.

Loading...